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Abstract. 
 
Formation of the synaptic basal lamina at 
vertebrate neuromuscular junction involves the accu-
mulation of numerous specialized extracellular matrix 
molecules including a specific form of acetylcholines-
terase (AChE), the collagenic-tailed form. The mecha-
nisms responsible for its localization at sites of nerveÐ
muscle contact are not well understood. To understand 
synaptic AChE localization, we synthesized a fluores-
 
cent conjugate of fasciculin 2, a snake 
 
a
 
-neurotoxin that 
tightly binds to the catalytic subunit. Prelabeling AChE 
 
on the surface of 
 
Xenopus
 
 muscle cells revealed that 
preexisting AChE molecules could be recruited to form 
clusters that colocalize with acetylcholine receptors at 
sites of nerveÐmuscle contact. Likewise, purified avian 
AChE with collagen-like tail, when transplanted to 
 
Xe-
nopus
 
 muscle cells before the addition of nerves, also 
accumulated at sites of nerveÐmuscle contact. Using ex-
ogenous avian AChE as a marker, we show that the 
collagenic-tailed form of the enzyme binds to the hepa-
ran-sulfate proteoglycan perlecan, which in turn binds 
to the dystroglycan complex through 
 
a
 
-dystroglycan. 
Therefore, the dystroglycanÐperlecan complex serves 
as a cell surface acceptor for AChE, enabling it to be 
clustered at the synapse by lateral migration within the 
plane of the membrane. A similar mechanism may un-
derlie the initial formation of all specialized basal lam-
ina interposed between other cell types.
 
Key words: acetylcholinesterase (AChE) • neuromus-
cular junction • perlecan • heparan-sulfate proteogly-
can • dystroglycan • basal lamina
 
A
 
CETYLCHOLINESTERASE
 
 (AChE)
 
1
 
 is concentrated at
the vertebrate neuromuscular junction (NMJ),
tightly associated with the synaptic basal lamina,
where it is responsible for terminating neurotransmission
(43). This highly localized accumulation of AChE is a con-
spicuous marker for the specialization of the junctional ex-
tracellular matrix (ECM) that accompanies acetylcholine
receptor (AChR) accumulation and synapse formation
(44). Despite considerable progress in understanding the
process of AChR clustering at this synapse, little is known
about the mechanism(s) responsible for the accumulation
of AChE and other components of the synaptic basal lam-
ina. As an integral membrane protein, the AChR under-
goes lateral movement within the plane of the cell mem-
brane to become clustered at sites of nerve–muscle contact
as a result of its association with the postsynaptic cytoskel-
eton (35). The synaptic AChE, on the other hand, is an
ECM-bound protein thus can not on its own associate with
the postsynaptic cytoskeleton for clustering. Except for
the observations that several specific components of the
synaptic basal lamina cocluster with AChR (reviewed in
25), little is known about how these molecules interact
with each other as well as how they become associated
with the neuromuscular synapse.
The predominant form of AChE at the NMJ is the
asymmetric, or A12, form consisting of three tetramers of
catalytic subunits covalently-linked to a collagen-like tail
(43). This form is tightly attached to the synaptic basal
lamina via its collagen-like tail and cannot be removed us-
ing chaotropic agents such as 8 M urea or 4 M guanidine
HCl (52). Only proteolysis can effectively remove the
AChE from the synaptic basal lamina (7, 24). The col-
lagen-like tail can bind to heparin and this property ap-
pears to be essential for the localization of this enzyme on
the muscle cell surface and its concentration at the NMJ
(30, 53, 56). Bacause heparan sulfate proteoglycan (HSPG)
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1. 
 
Abbreviations used in this paper:
 
 AChE, acetylcholinesterase; AChR,
acetylcholine receptor; BTX, 
 
a
 
-bungarotoxin; DG, dystroglycan; ECM,
extracellular matrix; HB-GAM, heparin-binding growth-associated mole-
cule; HSPG, heparan-sulfate proteoglycan; MTJ, myotendinous junc-
tion; NMJ, neuromuscular junction; OG-BTX, Oregon green-conjugated
 
a
 
-bungarotoxin; R-fasciculin 2, tetramethylrhodamine-conjugated fascic-
ulin 2; RU, resonance units. 
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is concentrated at the NMJ (3, 6, 57), it has been suggested
that this property of A12 AChE may underlie its synaptic
clustering (53).
By labeling cultured muscle cells with rhodamine-conju-
gated fasciculin 2 (R-fasciculin 2), a new fluorescent probe
for AChE, before the addition of synaptogenic stimuli
such as spinal cord neurons or growth factor-coated beads,
we have found that preexisting cell surface AChE mole-
cules become clustered at the site of postsynaptic devel-
opment. To identify molecules responsible for synaptic
AChE localization, we transplanted quail AChE to cul-
tured 
 
Xenopus
 
 muscle cells and visualized it using a spe-
cies-specific monoclonal antibody. The asymmetric form
of AChE (A12), but not the globular forms (G2/G4), bind
to and colocalizes precisely with perlecan, a major modu-
lar HSPG in skeletal muscle (32, 50). Perlecan itself binds
to dystroglycan (DG), a transmembrane protein complex
that interacts with molecules in the extracellular matrix
such as laminin and agrin as well as with the cytoskele-
ton (28, 50). Both perlecan and DG become clustered at
the postsynaptic membrane during NMJ formation (50).
These data are consistent with our in vivo observations
that endogenous AChE, detected with R-fasciculin 2,
colocalizes precisely with perlecan and DG and suggest
that AChE, via a transmembrane protein complex consist-
ing of HSPG and DG, can be clustered by lateral migra-
tion, followed by anchorage to the postsynaptic cytoskele-
tal scaffold.
 
Materials and Methods
 
Materials
 
Fasciculin 2 was obtained from Sigma Chemical Co. and 
 
a
 
-bungarotoxin
(BTX) was purchased from Biotoxins, Inc. Tetramethylrhodamine-conju-
gated fasciculin 2 and Oregon green 488-conjugated BTX were prepared
using the corresponding FluorReporter Protein Labeling Kit (Molecular
Probes) following the manufacturer’s recommended procedures and the
unreacted dyes removed using BioGel P-2 spin columns (Bio Rad Labora-
tories). Heparin (cat. no. H-2149) was obtained from Sigma Chemical Co.
 
Isolation and Purification of Quail AChE Forms
 
The globular and collagenic-tailed AChE forms were isolated from tissue-
cultured quail myotubes by detergent/high salt extraction followed by pre-
parative sucrose gradient sedimentation as previously described (55). The
pooled fractions from several gradients containing the G4 tetramers and
the G2 dimers (globular forms) or A12 collagenic-tailed AChE forms
were purified on an immunoaffinity column containing mAb 1A2 anti-
avian AChE antibody (54) covalently attached to Sepharose CL-4B at a
concentration of 1 mg/ml. The bound AChE was eluted with 0.1 M trieth-
ylamine, pH 11, in 1 M NaCl and 0.5% Triton X-100, and neutralized with
Tris-HCl to pH 7. The AChE concentration was estimated using radio-
metric assay (33).
 
Cell Culture and Labeling
 
The myotomal region of 
 
Xenopus
 
 
 
laevis
 
 embryos was excised and dissoci-
ated to make muscle cultures according to a previously published method
(47). To induce the formation of clusters of AChR or AChE, muscle cells
were cocultured with spinal cord neurons to establish the NMJ, or treated
with 10-
 
m
 
m polystyrene latex beads coated with recombinant heparin-
binding growth-associated molecule (HB-GAM) which also induces the
formation of postsynaptic specializations (49). To visualize endogenous
AChE, muscle cultures were labeled with R-fasciculin 2 at a concentration
of 150 nM for 0.5–1 h and then examined by fluorescence microscopy ei-
ther in the living state or after fixation with 95% ethanol at 
 
2
 
20
 
8
 
C. For
most experiments, the cultures were double-labeled with OG-BTX (at 150
 
nM) to visualize AChRs. To study the binding of exogenous AChE to the
surface of 
 
Xenopus
 
 muscle cells, cultures were incubated with either puri-
fied quail A12 collagenic-tailed AChE (at 0.1–0.2 ng/ml) or G2/G4 globu-
lar forms of AChE (at 0.5 ng/ml) for 1 h. The transplanted quail AChE
was then examined by labeling 
 
Xenopus
 
 cultures with mAb 1A2 followed
by fluorescently conjugated secondary antibody. HSPG at the cell surface
was detected with mAb HepSS-1, an anti-heparan sulfate monoclonal an-
tibody (Seikagaku Corp.). A polyclonal anti-perlecan antibody (27), a
generous gift of Dr. J. Hassell (Shriners Hospitals for Children, Tampa,
FL), was used to label this HSPG in 
 
Xenopus
 
 cells. The localization of DG
was studied with a monoclonal anti–
 
b
 
-DG antibody (Novacastra Labora-
tories). The HSPG and perlecan labeling was done on live cultures, but
the DG labeling was carried out after cell fixation and permeabilization
since the antibody recognizes an intracellular epitope of the transmem-
brane protein. To label 
 
Xenopus
 
 myotomal muscle fibers in vivo, the tail
of the larva was skinned, fixed, and incubated with the antibody. Alterna-
tively, the fibers within the tail musculature were first dissociated with col-
lagenase and then immunolabeled.
 
Binding of AChE Forms to Perlecan: Sepharose
Bead Assay
 
Purified anti-avian perlecan antibody mAb 33 (6) was prepared from
ascites fluid obtained by using the original hybridoma cell line (a gener-
ous gift from Dr. Douglas M. Fambrough, Johns Hopkins University,
Baltimore, MD). The purified antibody was absorbed onto protein
A–Sepharose CL-4B beads (Sigma Chemical Co.) to saturation, and the
beads washed extensively to remove unbound antibody. The beads were
then used to capture perlecan secreted by quail myotube cultures. Myo-
tube-conditioned medium from 5-d-old cultures was centrifuged 30 min at
12,000 
 
g
 
 and 500-
 
m
 
l aliquots of supernatant were incubated with 10 
 
m
 
l of
the mAb 33 beads overnight. After extensive washing with PBS contain-
ing 5 mM EDTA and 0.5% BSA, the beads were treated with 1 
 
m
 
M diiso-
propylfluorophosphate to irreversibly inhibit any trace amounts of endog-
enous AChE already bound to perlecan. After washing with PBS, EDTA,
and BSA, aliquots of immobilized perlecan beads were diluted in mi-
crofuge tubes with 500 
 
m
 
l PBS, 0.5 M NaCl, 1 mM EDTA, 0.5% BSA, and
0.5% Triton X-100 containing either 0.1–0.2 ng purified A12- or G4/G2-
AChE or buffer alone. After 1-h incubation at 5
 
8
 
C, the salt concentration
was decreased to 0.3 M NaCl and incubation continued overnight. The
next day the beads were washed three times with PBS, 5 mM EDTA, and
0.5% BSA and assayed for AChE activity using a radiometric assay as
previously described (54).
 
Binding of AChE Forms to Perlecan: BIAcore assay
 
AChE-perlecan binding was also assayed by the surface plasmon reso-
nance biosensor technology (42). A BIAcore X instrument (BIAcore.
Inc.) was used in this study. Perlecan purified from Englebreth-Holm-
Swarm tumor (37), kindly provided by Dr. J. Hassell (Shriners Hospitals
for Children, Tampa, FL), was conjugated to BIAcore sensor chip CM5
with carboxylated dextran surface. The chip surface was first treated with a
mixture of 
 
N
 
-hydroxysuccinimide (NHS, 50 mM) and 1-ethyl-3-(3-dimethyl-
aminopropyl) carbodiimide (EDC, 200 mM) in Hepes-buffered saline
(HBS, 10 mM Hepes, 150 mM NaCl, 3 mM EDTA, and 0.005% surfactant
P20, pH 7.4). After washing with HBS, the perlecan sample, diluted to a
concentration of 30 ng/ml with 100 mM Na-acetate buffer at pH 5, was in-
jected into the flow cell to effect coupling and this process was terminated
with 1 M ethanolamine (pH 8.5). Samples were then injected into the flow
cell to study their binding to perlecan. Globular G2/G4 AChE was diluted
to a concentration of 10 ng/ml and asymmetric A12 AChE was diluted to
2.3 ng/ml with HBS immediately before injection and 20 
 
m
 
l of each sample
was injected into the flow cell. The change in resonance units (RU), indic-
ative of the binding and dissociation, was continuously recorded with a
computer. The data were analyzed with BIAevaluation software supplied
by the manufacturer and plotted with SigmaPlot software (SPSS, Inc.).
 
Results
 
Distribution of AChE on Xenopus Muscle Visualized 
with Fluorescent Fasciculin 2
 
Fasciculin 2, a 61–amino acid snake 
 
a
 
-neurotoxin isolated
from the venom of African mambas, binds specifically and 
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tightly to the catalytic subunit of AChE (9, 34). The crystal
structure of the AChE-fasciculin 2 complex has been de-
termined and the molecular interactions between the toxin
and the enzyme are well characterized (9, 19, 26). To study
the distribution and fate of AChE, we synthesized a tet-
ramethylrhodamine conjugate of fasciculin 2 to label the
enzyme on muscle cells. When the cutaneous pectoris
muscle of the frog (
 
Rana pipiens
 
) was double-labeled with
R-fasciculin 2 and OG-BTX, a precise colocalization pat-
tern of AChE and AChR was observed. Fig. 1, A and B
show a single muscle fiber imaged in whole mount. Like
AChRs, AChE labeling also exhibits a banding pattern
typical of the frog NMJ. Detailed analyses of the R-fascic-
ulin 2 labeling pattern by conventional and confocal mi-
croscopy have shown a more precise registration of AChE
and AChR at the NMJ than the pattern hitherto observed
with histochemical or immunocytochemical methods (Ro-
tundo, R.L., and H.B. Peng, manuscript in preparation).
Since 
 
Xenopus
 
 myotomal muscle cells were used to
study AChE clustering in this study, we also examined
AChE distribution in the tail musculature of the larva with
R-fasciculin 2. As shown in Fig. 1 (C and D), R-fasciculin 2
labeling was colocalized with sites of AChR clustering at
NMJs revealed by OG-BTX labeling. In addition to the
NMJ, R-fasciculin 2 also labeled myotendinous junctions
(MTJs) which are located adjacent to the NMJs at the
intersomitic area (Fig. 1, E and F). The MTJ labeling
showed up as a series of streaks oriented longitudinally at
the ends of the myotome. These streaky structures corre-
spond to membrane invaginations where myofibrils insert
into the sarcolemma (13, 46). This MTJ localization of
AChE revealed by R-fasciculin 2 is consistent with previ-
ous histochemical results (16, 41).
 
Clustering of Endogenous AChE Studied
with R-Fasciculin 2
 
To study the clustering of AChE, cultured 
 
Xenopus
 
 myo-
tomal muscle cells were labeled with R-fasciculin 2. As
shown in Fig. 2 (A and B), R-fasciculin 2 labeling was ob-
served at spontaneously formed AChR clusters on these
muscle cells, and the pattern of AChE labeling closely re-
sembled that of the AChR. Virtually all AChR hot spots
observed were associated with AChE. Previous studies
have shown that AChR clusters at the NMJ are derived, at
least in part, from the preexisting pool of cell surface re-
ceptors by lateral migration (2). To determine whether
preexisting AChE molecules could also contribute to syn-
aptic clusters, muscle cells were prelabeled with R-fascicu-
lin 2 and then cocultured with spinal cord neurons or
treated with beads coated with HB-GAM, which mimic
the nerve in inducing postsynaptic specializations (49). As
shown in Fig. 2, preexisting AChE labeled with R-fascicu-
lin 2 became concentrated at bead-induced AChR clusters
(C and D) and at the developing NMJ (F–H) marked by
OG-BTX. These results were based on observations made
on a total of six separate nerve–muscle and bead–muscle
cocultures encompassing 
 
.
 
100 cell pairs each. Consis-
tently, AChE clustering as evidenced by R-fasciculin 2 la-
beling was detected at a much smaller percentage of
nerve- or bead-induced AChR clusters in 1-d cocultures
Figure 1. Distribution of AChE in skeletal muscle revealed by
fluorescent fasciculin 2 labeling. The cutaneus pectoris muscle of
Rana pipiens was double-labeled with R-fasciculin 2 (A) and
OG-BTX (B) in whole mount and single fibers were isolated for
observation. Colocalization of AChE and AChR is observed.
Like AChRs, the distribution of AChE molecules exhibits the
characteristic banding pattern associated with the junctional
folds. (C–F) R-fasciculin 2 and OG-BTX labeling of Xenopus lar-
val myotomal muscle. AChE is concentrated at both ends of the
myotomal muscle fibers (C) where AChRs are also clustered as
shown by OG-BTX labeling (D). (E) At higher magnification,
the details of AChE localization are resolved. The enzyme is
present both at the NMJ, marked by AChR labeling (F), and at
the MTJ as shown by the streaky R-fasciculin 2 labeling pattern
(E) which corresponds to deep membrane invaginations at this
sarcolemmal specialization. 
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(
 
z
 
20%) than in 2-d cocultures (
 
.
 
70%). This suggests that
AChE clustering lags behind AChR clustering by 
 
z
 
1 d.
The fluorescence intensity of R-fasciculin 2 labeling at
the cluster was generally several-fold less than that of the
corresponding OG-BTX labeling when each was normal-
ized with respect to the background. This suggests that the
site density of AChE at the cluster is significantly less than
that of the receptor. Since AChE is a secreted molecule, it
is possible that most of the molecules are secreted into the
medium and not captured by the cell surface acceptors (to
be described below) in tissue culture. Alternatively, it is
possible that not all AChE molecules are available for fas-
ciculin 2 labeling, and that the toxin’s affinity for AChE
decreases with time.
More importantly, however, these data show that, like
AChRs, preexisting cell surface AChE molecules can be
recruited to form clusters and suggest that they are capa-
ble of undergoing lateral migration at the cell surface to
become aggregated at sites of synaptic stimulation.
 
Transplantation of Exogenous AChE onto Xenopus 
Muscle Cells: Colocalization with Perlecan
 
To identify the molecules on the cell surface that can serve
as acceptors for AChE during the process of synaptic lo-
calization, we transplanted exogenous AChE to cultured
 
Xenopus
 
 muscle cells by adapting a method previously
used to study the localization of this enzyme at the NMJ in
vivo (56). The collagenic-tailed A12 AChE form or the
globular AChE forms consisting of dimers (G2) and tet-
ramers (G4) of catalytic subunits were purified from cul-
tured quail myotubes and applied to cultured 
 
Xenopus
 
muscle cells at a concentration of 0.1–0.4 ng/ml. Their
binding to the cell surface was then detected with mAb
1A2 which specifically labels the catalytic subunit of quail
AChE but not the 
 
Xenopus
 
 enzyme (54, 56).
The transplanted collagenic-tailed A12 form of AChE
bound to the surface of 
 
Xenopus
 
 muscle cells in a clus-
tered manner (Figs. 3 A and 4 A), where they often colo-
calized with AChR hot spots (Fig. 4, A and B), or some-
times more diffusely (Figs. 3 C). Although the pattern of
the AChE clusters bore similarity to that of AChRs, they
were not congruent with each other. The AChE cluster
generally occupied a larger area than the AChR cluster.
As it is known that the A12 AChE binds to heparin via its
collagen-like tail to be sequestered on the muscle cell sur-
face and at the NMJ (30, 53, 56), we examined whether
transplanted A12 AChE was associated with HSPG on the
cell surface. Pretreatment of muscle cells with heparin at a
concentration of 20 
 
m
 
g/ml abolished the binding of A12
AChE to the cell surface (data not shown). Perlecan is an
abundant HSPG on the surface of skeletal muscle and ap-
pears to play an important role in muscle differentiation
(31, 45, 50, 51). We thus examined its relationship to
AChE. Although this molecule is generally considered as
an ECM-bound HSPG, our recent study has shown that a
pool of perlecan is actually associated with the cell mem-
brane by interacting with 
 
a
 
-DG in skeletal muscle cells
(50). In fact, the bulk of perlecan on cultured 
 
Xenopus
 
muscle cells is cell membrane-associated since these cells
secret relatively small amount of matrix molecules and do
not form organized basal lamina under culture conditions
Figure 2. AChE clustering in cultured Xenopus muscle cells. (A
and B) A spontaneously formed hot spot of AChE and AChR vi-
sualized by R-fasciculin 2 and OG-BTX labeling. (C–E) An
AChE cluster induced by a HB-GAM–coated bead. The culture
was prelabeled with R-fasciculin 2 and OG-BTX before bead ap-
plication. Thus, this cluster was formed from preexistent AChE
and AChR. (F–H) Clustering of preexistent AChE at the NMJ.
The muscle culture was innervated with spinal cord neurons after
prelabeling with fluorescent toxins. Both AChE and AChR be-
come clustered at sites of nerve–muscle contact (indicated by ar-
rows in H) formed along the length of this neurite. 
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of this study. To determine whether AChE codistributed
with perlecan, anti-avian AChE mAb 1A2 and a poly-
clonal anti-perlecan antibody (27) were used to double-
label A12 AChE-treated muscle cells (Fig. 3, A–D). Both
clustered and diffusely distributed quail A12 AChE mole-
cules were precisely colocalized with perlecan. In the clus-
tered state (Fig. 3 A, B), the patterns of AChE and perle-
can labeling coincided nearly perfectly while even in the
diffuse state (Fig. 3, C and D), the puncta of labeling by
these two antibodies also showed precise registration.
These data, based on six transplantation experiments, thus
strongly suggest that A12 AChE binds to perlecan.
In contrast to A12 AChE, globular G2/G4 AChE forms,
which do not have the collagen-like tail and do not interact
with HSPGs, showed little binding to the cell surface when
applied at similar concentrations (Fig. 5). Moreover, the
binding of these globular AChE forms bore no relation-
ship to the pattern of perlecan labeling on the cell surface
(Fig. 5, A and B).
 
Purified A12 AChE Binds to Perlecan via its
Collagen-like Tail
 
To determine whether AChE could bind directly to perle-
can, purified A12 or globular G2/G4 AChE forms were in-
cubated with perlecan immobilized on mAb 33-conjugated
Figure 3. Transplantation of quail AChE onto Xenopus muscle
cells. Cultured Xenopus muscle cells were incubated with col-
lagenic-tailed quail A12 AChE and its binding to the cell surface
detected with avian AChE-specific mAb 1A2. Transplanted
AChE colocalized with perlecan on the cell surface in both the
clustered (A and B) and diffuse states (C and D). Arrows point
to the precise correspondence between the AChE and perlecan
labeling.
Figure 4. Transplanted collagenic-tailed AChE is enriched at
AChR clusters. (A and B) Attachment of A12 AChE to sites of
AChR accumulation on Xenopus muscle cells. (C and D) Clus-
tering of transplanted A12 AChE at the NMJ. After the muscle
culture was treated with exogenous AChE, it was innervated by
spinal neurons to induce NMJ formation. This AChE, detected
by mAb 1A2, becomes clustered at the developing NMJ. 
The Journal of Cell Biology, Volume 145, 1999 916
 
Sepharose beads. Beads incubated with bovine serum al-
bumin, rather than perlecan-containing conditioned me-
dium, were used as an additional control for nonspecific
binding in these experiments. As shown in Fig. 6 A, the
purified A12 AChE was bound to isolated perlecan. That
the binding occurred in 0.3 M NaCl, which was necessary
to prevent aggregation of the A12 AChE, suggests that it
is with high affinity. In contrast, the globular G2/G4 oligo-
meric forms showed binding levels similar to the albumin
control.
It could be argued that A12 AChE binds indirectly to
the antibody-perlecan beads via other molecules in the
conditioned medium. Thus, a second set of binding studies
using surface-plasmon resonance (BIAcore) technology
was conducted. In these experiments, purified perlecan
was covalently linked to the sensor chip. Samples of G2/
G4 and A12 AChE were then injected into the experimen-
tal chamber (flow cell) sequentially to study their interac-
tions with the bound perlecan. In this assay, the binding is
measured optically and expressed as the net increase in
resonance units (RU) at the termination of sample injec-
tion. As shown in Fig. 6 B, buffer injection did not result in
any increase in RU. Using this as a baseline, G2/G4 (at 0.2
ng in 20-
 
m
 
l sample volume) did not show any significant
binding to perlecan. When A12 was injected (at 0.05 ng in
20-
 
m
 
l sample volume), a 270-fold change in RU over the
G2/G4 value was seen, indicative of its binding to perle-
can. This binding was not reversed by the running buffer
that had 150 mM NaCl. Significant dissociation of A12
from the perlecan surface was only observed after a buffer
with 1–2 M NaCl was injected into the flow cell as shown
in Fig. 6 B.
Figure 5. Nonspecific binding of globular G2/G4 forms of quail
AChE to Xenopus muscle cells. The AChE was detected with
mAb 1A2 (A) and the cell was double-labeled with anti-perlecan
antibody (B). In comparison to A12 AChE, these forms showed
only low level, non-specific binding to the cell surface without
any correlation with the perlecan labeling.
Figure 6. Binding of AChE to perlecan. (A) Binding of AChE to
perlecan-conjugated Sepharose beads. Perlecan secreted by quail
myotubes was captured on mAb #33-conjugated Sepharose
beads which were then used to determine the binding of AChE
to this HSPG. The AChE bound to the beads was quantified by
radiometric assay. Only the collagenic-tailed A12 form of AChE
exhibited strong binding to perlecan. The binding of the globular
G2/G4 forms showed only background activity. (B) Binding as-
sayed with BIAcore. Perlecan was covalently conjugated to a
sensor chip and this surface was used to assess the binding of
AChE. Samples were injected into the flow cell over the chip and
the net change in RU at the termination of the sample injection
and buffer wash was plotted. Using buffer injection as the base-
line, G2/G4 AChE showed nearly no binding to perlecan. In con-
trast, A12 AChE showed strong binding, which was only re-
versed by high salt. The samples were injected sequentially as
shown in the abscissa (from left to right). For each sample, the
mean of 20 data points and the standard deviation are given at
the bottom of the trace. 
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These biochemical measurements thus show that A12
AChE binds directly to perlecan through its collagen-like
tail and provide further support to our conclusion that cell
surface perlecan serves as an acceptor for the synaptic A12
form of AChE. They are consistent with the cellular bind-
ing studies described above (Figs. 3 and 5). The fact that
these two molecules are only dissociated under high salt
condition is consistent with the notion that the binding
is mediated by the heparan-sulfate glycosaminoglycan
chains on perlecan.
 
Neurons Induce Clustering of Transplanted Avian 
AChE to Sites of Nerve–Muscle Contact
 
To determine whether the transplanted AChE can be re-
cruited to form clusters at the NMJ, we innervated muscle
cells pretreated with quail A12 AChE. As shown in Fig. 4
(C and D), this exogenous AChE was also clustered at
developing NMJs revealed by R-BTX labeling. Again,
the organization of the AChE cluster was not precisely
aligned with that of the AChR clusters with the AChE
cluster generally occupying a larger area than the AChR
cluster. In contrast to the endogenous AChE, the NMJ lo-
calization of the transplanted AChE was clearly detect-
able in 1-d nerve–muscle cocultures (see Discussion).
Thus, similar to endogenous AChE, the transplanted
AChE can also be clustered by lateral migration at the cell
surface.
 
The Role of Perlecan and Dystroglycan in
AChE Clustering
 
Accompanying the clustering of AChE, HSPGs also be-
came concentrated at the NMJ (3, 6, 50). To determine
whether preexisting perlecan molecules can undergo lat-
eral migration and become clustered, cultured muscle cells
were labeled with anti-perlecan antibody and then treated
with HB-GAM–coated beads followed by fluorescently
conjugated secondary antibodies. As shown in Fig. 7 (A
and B), preexistent perlecan was indeed clustered in re-
sponse to the bead stimulation. Together with AChE bind-
ing to perlecan described above, these results suggest that
the AChE-perlecan complex at the cell surface can be re-
cruited to form synaptic clusters. As neither AChE nor
perlecan is a transmembrane protein, an integral mem-
brane linker for this complex would be necessary to effect
its lateral migration at the cell surface.
The core protein of perlecan contains three globular do-
mains at its COOH terminus that are also shared by lami-
nin A-chain and agrin (32). Recently, we have shown that,
like laminin and agrin, perlecan can bind directly to 
 
a
 
-DG
which is the extracellular component of the transmem-
brane DG glycoprotein complex and that these two pro-
teins cocluster in response to synaptic stimuli such as
spinal neurons and HB-GAM–coated beads (50). An ex-
ample of this coclustering induced by beads is shown in
Fig. 7 (C and D). Here both perlecan and DG become
clustered at the bead–muscle contact and there is a high
degree of registration between clusters of these two mole-
cules. To determine whether AChE was also colocalized
with DG, we double-labeled bead-treated muscle cells and
nerve–muscle cocultures with R-fasciculin 2 and anti–
 
b
 
-DG
antibody. As shown in Fig. 8, AChE and DG also appeared
to be precisely coclustered at sites of nerve–muscle con-
tacts (A and B) and at bead-induced clusters (C and D).
To correlate these data obtained from cultured muscle
cells with AChE clustering in vivo, we examined the re-
lationship between AChE, perlecan, and DG in whole
mounts of myotomal muscle. As shown in Fig. 9 (A and
B), AChE and perlecan are colocalized at both the NMJ
and the MTJ. Double-labeling myotomal muscle with
anti–
 
b
 
-DG antibody and fluorescent BTX revealed that
DG is also clustered at the MTJ in addition to its being
present at the postsynaptic membrane (Fig. 9, C and D).
Finally, double-labeling myotomal muscle with 
 
b
 
-DG anti-
body and R-fasciculin 2 showed colocalization of DG and
AChE at intersomitic junctions (Fig. 9, E and F). At
higher magnification, the colocalization of these two mole-
cules at ends of the muscle fiber, where NMJs are located,
and along MTJ invaginations became more evident (Fig. 9,
G and H).
These data thus suggest that the perlecan-DG complex
can serve as an acceptor for the collagenic-tailed form of
AChE and allow it to assume an association with the mus-
cle membrane. This membrane association may provide
the structural basis for the observed clustering of preexis-
tent membrane-bound AChE to the synaptic site.
 
Discussion
 
In this study, we used fluorescently conjugated fasciculin 2
to follow the clustering of AChE during NMJ formation.
This probe has many of the same advantages as fluores-
cent 
 
a
 
-bungarotoxin which has offered an extremely pow-
Figure 7. Clustering of preexistent perlecan induced by HB-
GAM–coated beads. The muscle cell was prelabeled with anti-
perlecan antibodies, treated with HB-GAM–coated beads, and
then labeled with fluorescent secondary antibody 24 h later (A
and B). (A) Distribution of perlecan at site of bead contact; (B)
localization of HB-GAM–coated bead. All sites of perlecan accu-
mulation at sites of bead contact (C) also showed accumulation
of DG (D). 
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erful tool for visualizing AChRs (1). Its compact size al-
lows it to penetrate more deeply into tissues than antibody
reagents. Its specificity and 1:1 stoichiometry in binding to
the catalytic site of AChE (9) enables high-resolution im-
aging of AChE distribution on muscle cells. Iodinated fas-
ciculin 2 has recently been used to quantify AChE site
density in mammalian muscle by EM-autoradiography (4).
To our knowledge, the current work is the first to utilize
fluorescent fasciculin for optical imaging of AChE.
We have shown that a preexistent, membrane-bound
collagenic-tailed form of AChE, either endogenously de-
posited or experimentally transplanted can be recruited to
form clusters at the postsynaptic membrane. This suggests
that AChE is capable of lateral migration on the cell sur-
face and becomes immobilized at sites of synaptic differ-
entiation. Thus, AChE clustering seems to bear similarity
to the much studied AChR clustering process which can
be explained by a diffusion-mediated trapping mechanism
of AChRs preexistent on the cell surface (20, 35). Since
AChE in muscle is not a membrane-bound protein, this
necessitates one or more acceptor molecules to link it to
the cell surface. The immunocytochemical colocalization
and binding studies presented here show that perlecan is
one such acceptor for A12 AChE. Perlecan is one of at
least two modular HSPGs on the surface of skeletal mus-
cle cells, the other being muscle agrin (32). Although the
bulk of perlecan is associated with ECM, our recent stud-
ies have shown that a pool of this molecule is associated
with the cell surface in association with 
 
a
 
-DG (50). This
work suggests that this cell surface pool is, at least in part,
also involved in AChE anchorage. As AChE is secreted,
this membrane-bound perlecan could readily capture and
sequester it on the cell surface. This scheme is consistent
with previous findings that the heparin-binding property
of A12 AChE is essential for its localization on the cell
surface (53). The heparin-binding motifs within the col-
lagen-like tail of this AChE form have recently been eluci-
dated (18, 36). The interaction between this motif and the
heparan-sulfate side chain on the perlecan molecule seems
to be the basis for the localization of this enzyme to the
cell surface (53, 56). Despite our focus on perlecan, muscle
agrin, which also becomes concentrated at sites of synaptic
differentiation (38), may also be an acceptor for A12
Figure 8. Colocalization of AChE and DG in culture. Endoge-
nous AChE was labeled with R-Fasciculin 2 and DG was labeled
with anti–b-DG antibody followed by FITC-conjugated second
antibody. (A and B) Colocalization of AChE and DG at a NMJ.
(C and D) Colocalization of AChE and DG at a bead–muscle
contact.
Figure 9. Colocalization of AChE, perlecan and DG on myoto-
mal muscle fibers in vivo. (A and B) Perlecan and AChE colocal-
ization at the ends of myotomal muscle fibers. Arrows point to
the membrane invaginations of the myotendinous junction. (C
and D) Clustering of DG at the NMJ, marked by AChR clusters
(D) labeled with fluorescent a-bungarotoxin, and at the myoten-
dinous junction (arrows). (E and F) Colocalization of DG and
AChE at intersomitic junctions (low magnification). (G–H)
Colocalization of DG and AChE at sarcolemma specializations
shown at higher magnification. Arrows point to invaginations of
the myotendinous junction. 
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AChE. Our preliminary studies based on immunological
labeling have shown that agrin can coexist with perlecan at
the same loci on the cell membrane, albeit at a lower con-
centration.
Previous studies have shown that 
 
a
 
-DG can interact
with ECM-bound molecules that have G-domain motifs,
such as laminin, agrin, and perlecan (10–12, 22, 28, 50, 58).
On the other hand, 
 
b
 
-DG, the transmembrane component
of the DG complex, interacts with dystrophin or utrophin
via its cytoplasmic tail (28). Thus, the DG complex is capa-
ble of mediating the transmembrane linkage between
ECM and the cytoskeleton. This study suggests a new role
for DG as a component of the machinery for cell surface
sequestration and clustering of AChE and other ECM
components in skeletal muscle during synaptogenesis as
depicted in a model in Fig. 10. The transmembrane nature
of the DG complex may allow it to undergo lateral move-
ment within the plane of the membrane in the nonclus-
tered state and thus to move its bound HSPG-AChE com-
plex in a manner similar to the AChRs (Fig. 10 A). The
lateral mobility of DG is also supported by the recent
demonstration that exogenously applied laminin induces
clustering of DG (15).
The mechanism for DG clustering at the synaptic site is
unknown, although it may also be a cytoskeleton-medi-
ated process as is the case of AChR clustering (8). For
AChR clustering, there is compelling evidence to suggest
that synaptogenic stimuli induce the formation of a
postsynaptic cytoskeletal scaffold which serves to immobi-
lize freely diffusing receptors. Lateral diffusion of AChRs,
with a diffusion coefficient estimated to be on the order of
10
 
2
 
10
 
–10
 
2
 
9
 
 cm
 
2
 
/s, can account for the rate of AChR clus-
tering induced by synaptogenic signal (35, 48). The cyto-
skeletal specialization underlying the postsynaptic mem-
brane, including F-actin, utrophin/dystrophin, and the
transmembrane sarcoglycan complex (25, 39) may be in-
volved in the clustering and/or stabilization of the DG-
HSPG-AChE complex (Fig. 10 B). The coclustering of
AChE and AChR suggests that their clustering processes
may share common determinants. Subtle differences, how-
ever, must also exist as shown by the lack of congruency
between these two types of clusters with the AChE clus-
ter being larger than the AChR cluster. In the same man-
ner, it has been shown that clusters of dystroglycan and
HB-GAM, which binds to HSPG, are also more extensive
in area than AChR clusters despite their colocalization
(14, 49).
Recent studies have shown that postsynaptic specializa-
tions, including both AChR and AChE clusters, still form
in utrophin and dystrophin double-knockout mice despite
their severe muscular dystrophy (17, 23). However, AChE
appears to be “more scattered” according to one study
(17). This could be due to two reasons. First, the postjunc-
tional folds are greatly reduced in these animals. Because
Figure 10. Model illustrat-
ing the involvement of the
dystroglycan-perlecan com-
plex in synaptic localiza-
tion of the collagenic-tailed
AChE form. (A) Before in-
nervation, the COOH termi-
nus of perlecan can interact
with the transmembrane DG
complex (50). The A12 col-
lagenic-tailed AChE in turn
binds to the heparan-sulfate
chains of perlecan via its col-
lagen-like tail. This associa-
tion with a transmembrane
protein complex enables the
AChE to undergo lateral
movement (arrows) on the
cell surface in the similar
manner as AChRs. (B) In re-
sponse to innervation, the
AChE-perlecan-DG complex
is clustered by a mechanism
similar to the lateral migra-
tion-mediated localization of
AChRs. Other postsynaptic
proteins, such as dystrophin,
utrophin, syntrophin, and the
sarcoglycan complex, as well
as F-actin, may be involved
in the formation and/or the
stabilization of the cluster. 
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synaptic AChE is associated with the basal lamina both on
the top of and along the folds in normal muscle (44), their
reduction should result in a significant deficit of AChE.
Furthermore, the level of DG at the NMJ also seems to be
reduced, although the exact level seems to vary between
the two studies (17, 23). This could also reduce the total
amount of AChE at the NMJ according our model. Never-
theless, the DG remaining at the NMJ may offer the struc-
tural basis of AChE localization even in these animals.
Our results have shown that the clustering of endoge-
nous AChE lags behind that of AChRs by about a day in
tissue culture. However, transplanted AChE becomes de-
tectable at newly established NMJs on the same day as the
AChRs. This suggests that the machinery for AChE clus-
tering is activated at the time of synaptic stimulation, but
other factors may limit the rate of AChE accumulation in
cultured muscle cells. A previous study has shown that DG
clustering is detectable on cultured 
 
Xenopus
 
 muscle cells
within the first 1–2 h after nerve contact (14). Thus, the de-
lay in AChE accumulation seems to be quantitative in na-
ture due to the site density of this molecule on the muscle
surface. As described above, the fluorescence intensity of
R-fasciculin 2 labeling of AChE at clusters is generally
much lower than that of AChR labeling. In fact, the site
density of AChE at frog NMJ is estimated to be 
 
z
 
600
sites/
 
m
 
m
 
2
 
 as compared with 10,000 sites/
 
m
 
m
 
2
 
 for AChRs
(5, 21). A factor that could limit the amount of membrane-
bound AChE is the number of sites available for its bind-
ing on the heparan-sulfate chains of HSPGs. In addition to
AChE, these chains also offer a substrate for other hep-
arin-binding molecules such as several ECM components
(59) and growth factors (49) for their localization at the
cell surface. The low site density may thus account for the
length of time necessary for its accumulation to detect-
able level at synaptic sites. Transplantation of exogenous
AChE greatly increases its site density on the cell surface
as shown by the visualization of diffusely distributed mole-
cules (Fig. 3 C).
The clustering of AChE is an example of the specializa-
tion of synaptic basement membrane during NMJ forma-
tion. A recent study using DG-null embryoid bodies has
shown that this protein plays a central role in the assembly
of the basement membrane (29). In addition to AChE, the
scheme presented in this work based on molecular interac-
tion with HSPG-DG complex may also find application in
the formation of other specializations involving heparin-
binding synaptic molecules such as neuregulin and peptide
growth factors (40, 49).
 
We thank Dr. Douglas Fambrough for the mAb 33 hybridoma, Dr. John
R. Hassell for purified perlecan and its antibody, and Dr. Heikki Rauvala
for recombinant HB-GAM.
This work was supported by National Institutes of Health grants NS-
23583 (to H.B. Peng) and AG-05917 (to R.L. Rotundo) and by the Muscu-
lar Dystrophy Association (to H.B. Peng).
Received for publication 1 December 1998 and in revised form 12 March
1999.
 
References
 
1. Anderson, M.J., and M.W. Cohen. 1974. Fluorescent staining of acetylcho-
line receptors in vertebrate skeletal muscle. 
 
J. Physiol. (Lond.)
 
 237:385–
400.
2. Anderson, M.J., and M.W. Cohen. 1977. Nerve-induced and spontaneous
 
redistribution of acetylcholine receptors on cultured muscle cells. 
 
J.
Physiol. (Lond.)
 
 268:757–773.
3. Anderson, M.J., and D.M. Fambrough. 1983. Aggregates of acetylcholine
receptors are associated with plaques of a basal lamina heparan sulfate
proteoglycan on the surface of skeletal muscle fibers. 
 
J. Cell Biol.
 
 97:
1396–1411.
4. Anglister, L., J. Eichler, M. Szabo, B. Haesaert, and M.M. Salpeter. 1998.
 
125
 
I-labeled fasciculin 2: a new tool for quantitation of acetylcholines-
terase densities at synaptic sites by EM-autoradiography. 
 
J. Neurosci.
Methods
 
 81:63–71.
5. Anglister, L., J.R. Stiles, and M.M. Salpeter. 1994. Acetylcholinesterase
density and turnover number at frog neuromuscular junctions, with mod-
eling of their role in synaptic function. 
 
Neuron.
 
 12:783–794.
6. Bayne, E.K., M.J. Anderson, and D.M. Fambrough. 1984. Extracellular
matrix organization in developing muscle: correlation with acetylcholine
receptor aggregates. 
 
J. Cell Biol.
 
 99:1486–1501.
7. Betz, W., and B. Sakmann. 1973. Effects of proteolytic enzymes on func-
tion and structure of frog neuromuscular junctions. 
 
J. Physiol. (Lond.)
 
230:673–688.
8. Bloch, R.J., and D.W. Pumplin. 1988. Molecular events in synaptogenesis:
nerve-muscle adhesion and postsynaptic differentiation. Am. J. Physiol.
254:C345–C364.
9. Bourne, Y., P. Taylor, and P. Marchot. 1995. Acetylcholinesterase inhibi-
tion by fasciculin: crystal structure of the complex. Cell. 83:503–512.
10. Bowe, M.A., and J.R. Fallon. 1995. The role of agrin in synapse formation.
Annu. Rev. Neurosci. 18:443–462.
11. Bowe, M.A., K.A. Deyst, J.D. Leszyk, and J.R. Fallon. 1994. Identification
and purification of an agrin receptor from Torpedo postsynaptic mem-
branes: A heteromeric complex related to the dystroglycans. Neuron. 12:
1173–1180.
12. Campanelli, J.T., S.L. Roberds, K.P. Campbell, and R.H. Scheller. 1994. A
role for dystrophin-associated glycoproteins and utrophin in agrin-
induced AChR clustering. Cell. 77:663–674.
13. Chen, Q., R. Sealock, and H.B. Peng. 1990. A protein homologous to the
Torpedo postsynaptic 58K protein is present at the myotendinous junc-
tion. J. Cell Biol. 110:2061–2071.
14. Cohen, M.W., C. Jacobson, E.W. Godfrey, K.P. Campbell, and S. Carbo-
netto. 1995. Distribution of a-dystroglycan during embryonic nerve-mus-
cle synaptogenesis. J. Cell Biol. 129:1093–1101.
15. Cohen, M.W., C. Jacobson, P.D. Yurchenco, G.E. Morris, and S. Carbo-
netto. 1997. Laminin-induced clustering of dystroglycan on embryonic
muscle cells: comparison with agrin-induced clustering. J. Cell Biol. 136:
1047–1058.
16. Couteaux, R. 1955. Localization of cholinesterase at neuromuscular junc-
tions.  In International Review of Cytology. G.H. Bourne and J.F.
Danielli, editors. Academic Press, New York. 335–375.
17. Deconinck, A.E., J.A. Rafael, J.A. Skinner, S.C. Brown, A.C. Potter, L.
Metzinger, D.J. Watt, J.G. Dickson, J.M. Tinsley, and K.E. Davies. 1997.
Utrophin-dystrophin-deficient mice as a model for Duchenne muscular
dystrophy. Cell. 90:717–727.
18. Deprez, P.N., and N.C. Inestrosa. 1995. Two heparin-binding domains are
present on the collagenic tail of asymmetric acetylcholinesterase. J. Biol.
Chem. 270:11043–11046.
19. Eastman, J., E.J. Wilson, C. Cervenansky, and T.L. Rosenberry. 1995. Fas-
ciculin 2 binds to the peripheral site on acetylcholinesterase and inhibits
substrate hydrolysis by slowing a step involving proton transfer during
enzyme acylation. J. Biol. Chem. 270:19694–19701.
20. Edwards, C., and H.L. Frisch. 1976. A model for the localization of acetyl-
choline receptors at the muscle endplate. J. Neurobiol. 7:377–381.
21. Fertuck, H.C., and M.M. Salpeter. 1974. Localization of acetylcholine re-
ceptor by 125I-labeled a-bungarotoxin binding at mouse motor endplates.
Proc. Natl. Acad. Sci. USA. 71:1376–1378.
22. Gee, S.H., F. Montanaro, M.H. Lindenbaum, and S. Carbonetto. 1994.
Dystroglycan-a, a dystrophin-associated glycoprotein, is a functional
agrin receptor. Cell. 77:675–686.
23. Grady, R.M., H.B. Teng, M.C. Nichol, J.C. Cunningham, R.S. Wilkinson,
and J.R. Sanes. 1997. Skeletal and cardiac myopathies in mice lacking
utrophin and dystrophin: a model for Duchenne muscular dystrophy.
Cell. 90:729–738.
24. Hall, Z.W., and R.B. Kelly. 1971. Enzymatic detachment of endplate ace-
tylcholinesterase from muscle. Nat. New Biol. 232:62–63.
25. Hall, Z.W., and J.R. Sanes. 1993. Synaptic structure and development: The
neuromuscular junction. Neuron. 10(Suppl):99–121.
26. Harel, M., G.J. Kleywegt, R.B. Ravelli, I. Silman, and J.L. Sussman. 1995.
Crystal structure of an acetylcholinesterase-fasciculin complex: interac-
tion of a three-fingered toxin from snake venom with its target. Structure.
3:1355–1366.
27. Hassell, J.R., P.G. Robey, H.J. Barrach, J. Wilczek, S.I. Rennard, and G.R.
Martin. 1980. Isolation of a heparan sulfate-containing proteoglycan
from basement membrane. Proc. Natl. Acad. Sci. USA. 77:4494–4498.
28. Henry, M.D., and K.P. Campbell. 1996. Dystroglycan: an extracellular ma-
trix receptor linked to the cytoskeleton. Curr. Opin. Cell Biol. 8:625–631.
29. Henry, M.D., and K.P. Campbell. 1998. A role for dystroglycan in base-
ment membrane assembly. Cell. 95:859–870.
30. Inestrosa, N.C., and A. Perelman. 1989. Distribution and anchoring of mo-Peng et al. Acetylcholinesterase Clustering at NMJ 921
lecular forms of acetylcholinesterase. Trends Pharmacol. Sci. 10:325–329.
31. Iozzo, R.V. 1994. The biology of perlecan: the multifaceted heparan sul-
phate proteoglycan of basement membrane and pericellular matrices.
Biochem. J. 302:625–639.
32. Iozzo, R.V., and A.D. Murdoch. 1996. Proteoglycans of the extracellular
environment: clues from the gene and protein side offer novel perspec-
tives in molecular diversity and function. FASEB J. 10:598–614.
33. Johnson, C.D., and R.L. Russell. 1975. A rapid, simple radiometric assay
for cholinesterase, suitable for multiple determinations. Anal. Biochem.
64:229–238.
34. Karlsson, E., P.M. Mbugua, and D. Rodriguez-Ithurralde. 1984. Fascicu-
lins, anticholinesterase toxins from the venom of the green mamba Den-
droaspis angusticeps. J. Physiol. (Paris) 79:232–240.
35. Kidokoro, Y., and B. Brass. 1985. Redistribution of acetylcholine receptors
during neuromuscular junction formation in Xenopus cultures. J. Physiol.
(Paris) 80:212–220.
36. Krejci, E., S. Thomine, N. Boschetti, C. Legay, J. Sketelj, and J. Massoulié.
1997. The mammalian gene of acetylcholinesterase-associated collagen.
J. Biol. Chem. 272:22840–22847.
37. Ledbetter, S.R., L.W. Fisher, and J.R. Hassell. 1987. Domain structure of
the basement membrane heparan sulfate proteoglycan. Biochemistry. 26:
988–995.
38. Lieth, E., and J.R. Fallon. 1993. Muscle agrin: neural regulation and local-
ization at nerve-induced acetylcholine receptor clusters. J. Neurosci. 13:
2509–2514.
39. Lim, L.E., and K.P. Campbell. 1998. The sarcoglycan complex in limb-gir-
dle muscular dystrophy. Curr. Opin. Neurol. 11:443–452.
40. Loeb, J.A., and G.D. Fischbach. 1995. ARIA can be released from extra-
cellular matrix through cleavage of a heparin-binding domain. J. Cell
Biol. 130:127–135.
41. Lubinska, L., and J. Zelena. 1967. Acetylcholinesterase at muscle-tendon
junctions during postnatal development in rats. J. Anat. 101:295–308.
42. Malmqvist, M. 1997. Biospecific interaction analysis using biosensor tech-
nology. Nature. 361:186–187.
43. Massoulié, J., L. Pezzementi, S. Bon, E. Krejci, and F.-M. Vallette. 1993.
Molecular and cellular biology of cholinesterases. Prog. Neurobiol. 41:
31–91.
44. McMahan, U.J., J.R. Sanes, and L.M. Marshall. 1978. Cholinesterase is as-
sociated with the basal lamina at the neuromuscular junction. Nature.
271:172–174.
45. Murdoch, A.D., B. Liu, R. Schwarting, R.S. Tuan, and R.V. Iozzo. 1994.
Widespread expression of perlecan proteoglycan in basement mem-
branes and extracellular matrices of human tissues as detected by a novel
monoclonal antibody against domain III and by in situ hybridization. J.
Histochem. Cytochem. 42:239–249.
46. Peng, H.B., and Q. Chen. 1992. Induction of dystrophin localization in cul-
tured Xenopus muscle cells by latex beads. J. Cell Sci. 103:551–563.
47. Peng, H.B., L.P. Baker, and Q. Chen. 1991. Tissue culture of Xenopus neu-
rons and muscle cells as a model for studying synaptic induction. Methods
Cell Biol. 36:511–526.
48. Peng, H.B., D.-Y. Zhao, M.-Z. Xie, Z. Shen, and K. Jacobson. 1989. The
role of lateral migration in the formation of acetylcholine receptor clus-
ters induced by basic polypeptide-coated latex beads. Dev. Biol. 131:197–
206.
49. Peng, H.B., A.A. Ali, Z. Dai, D.F. Daggett, E. Raulo, and H. Rauvala.
1995. The role of heparin-binding growth-associated molecule (HB-
GAM) in the postsynaptic induction in cultured muscle cells. J. Neurosci.
15:3027–3038.
50. Peng, H.B., A.A. Ali, H. Rauvala, J.R. Hassell, and N.R. Smalheiser. 1998.
The relationship between perlecan and dystroglycan and its implication
in the formation of the neuromuscular junction. Cell Adhesion Commun.
5:475–489.
51. Rogalski, T.M., B.D. Williams, G.P. Mullen, and D.G. Moerman. 1993.
Products of the unc-52 gene in Caenorhabditis elegans are homologous to
the core protein of the mammalian basement membrane heparan sulfate
proteoglycan. Genes Dev. 7:1471–1484.
52. Rossi, S.G., and R.L. Rotundo. 1993. Localization of “non-extractable”
acetylcholinesterase to the vertebrate neuromuscular junction. J. Biol.
Chem. 268:19152–19159.
53. Rossi, S.G., and R.L. Rotundo. 1996. Transient interactions between col-
lagen-tailed acetylcholinesterase and sulfated proteoglycans prior to im-
mobilization on the extracellular matrix. J. Biol. Chem. 271:1979–1987.
54. Rotundo, R.L. 1984. Purification and properties of the membrane-bound
form of acetylcholinesterase from chicken brain. J. Biol. Chem. 259:
13186–13194.
55. Rotundo, R.L. 1984. Asymmetric acetylcholinesterase is assembled in the
Golgi apparatus. Proc. Natl. Acad. Sci. USA. 81:479–483.
56. Rotundo, R.L., S.G. Rossi, and L. Anglister. 1997. Transplantation of quail
collagen-tailed acetylcholinesterase molecules onto the frog neuromus-
cular synapse. J. Cell Biol. 136:367–374.
57. Sanes, J.R., M. Schachner, and J. Covault. 1986. Expression of several ad-
hesive macromolecules (N-CAM, L1, J1, NILE, uvomorulin, laminin, fi-
bronectin, and a heparan sulfate proteoglycan) in embryonic, adult, and
denervated adult skeletal muscle. J. Cell Biol. 102:420–431.
58. Sugiyama, J., D.C. Bowen, and Z.W. Hall. 1994. Dystroglycan binds nerve
and muscle agrin. Neuron. 13:103–115.
59. Yurchenco, P.D., and J.C. Schittny. 1990. Molecular architecture of base-
ment membranes. FASEB J. 4:1577–1590.